{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T14:06:31Z","timestamp":1771250791750,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Nasopharyngeal carcinoma (NPC) is a distinct type of head and neck cancer with unique epidemiological and pathological characteristics. Inflammatory and nutritional markers have been increasingly recognized as prognostic indicators in cancer. In this study, we aim to evaluate the significance of the prognostic nutritional index (PNI) and C-reactive protein\/albumin ratio (CRP\/Alb) in the prognosis of patients with locally advanced nasopharyngeal carcinoma (NPC). Materials and Methods: We retrospectively analyzed a total of 78 patients diagnosed with locally advanced NPC who received chemoradiotherapy (CCRT) with or without induction or adjuvant chemotherapy between January 2010 and April 2024. Patient characteristics, treatment modalities, inflammatory and nutritional markers, overall survival (OS), and progression-free survival (PFS) were assessed. Kaplan\u2013Meier survival analysis and Cox regression models were used to evaluate the prognostic impact of PNI and CRP\/Alb. Results: A lower PNI (\u226452.90) and lower CRP\/Alb ratio (\u22640.14) were significantly associated with higher mortality risk (p = 0.043 and 0.023, respectively). Tumor size (\u226532.85 mm) was also found to be a significant prognostic factor (p = 0.041). Patients receiving CCRT alone or with adjuvant chemotherapy had a better OS and PFS compared to those who received induction chemotherapy plus CCRT (p = 0.028 and 0.002, respectively). Multivariate Cox regression analysis indicated that CCRT + AC (HR: 0.17, p = 0.029) and CCRT (HR: 0.25, p = 0.049) significantly reduced the risk of death. Conclusions: PNI and CRP\/Alb ratio are independent prognostic markers in locally advanced NPC, providing valuable insights into patient stratification and treatment optimization. These findings support their integration into routine clinical practice for risk assessment. Future large-scale, multicenter studies are warranted to confirm these findings.<\/jats:p>","DOI":"10.3390\/medicina62020377","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:37:28Z","timestamp":1771245448000},"page":"377","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Prognostic Nutritional Index and C-Reactive Protein\/Albumin Ratio in Prognosis of Locally Advanced Nasopharyngeal Carcinoma"],"prefix":"10.3390","volume":"62","author":[{"given":"Taliha G\u00fc\u00e7l\u00fc","family":"Kantar","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Denizli State Hospital, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolga","family":"Do\u011fan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Denizli State Hospital, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0734-0692","authenticated-orcid":false,"given":"Bur\u00e7in \u00c7akan","family":"Demirel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Medipol University, Istanbul 34214, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melek","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Denizli State Hospital, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semra","family":"Ta\u015f","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bedriye A\u00e7\u0131kg\u00f6z","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze Serin","family":"\u00d6zel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9140-1453","authenticated-orcid":false,"given":"Ceren Morda\u011f","family":"\u00c7i\u00e7ek","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu Yapar","family":"Ta\u015fk\u00f6yl\u00fc","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atike G\u00f6k\u00e7en","family":"Demiray","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"De\u011firmencio\u011flu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Denipol Hospital, Denizli 20010, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arzu","family":"Yaren","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"G\u00f6k\u00f6z Do\u011fu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"ref_1","unstructured":"Global Cancer Observatory (2023, December 13). International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.fr\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s12094-012-0872-5","article-title":"Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV nonsmall cell lung cancer","volume":"14","author":"Martinez","year":"2012","journal-title":"Clin. Transl. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hed.23567","article-title":"Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma","volume":"37","author":"Rassouli","year":"2015","journal-title":"Head Neck"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00432-014-1714-3","article-title":"The prognostic significance of the prognostic nutritional index in cancer: A systematic review and meta-analysis","volume":"140","author":"Sun","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/SLA.0000000000002985","article-title":"Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer","volume":"271","author":"Okadome","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/10408363.2011.599831","article-title":"Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer","volume":"48","author":"Allin","year":"2011","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11912-019-0799-x","article-title":"Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications","volume":"21","author":"Zanoni","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.immunol.021908.132544","article-title":"Immune therapy for cancer","volume":"27","author":"Dougan","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jab\u0142o\u0144ska, B., Pawlicki, K., and Mrowiec, S.J.C. (2021). Associations between Nutritional and Immune Status and Clinicopathologic Factors in Patients with Pancreatic Cancer: A Comprehensive Analysis. Cancers, 13.","DOI":"10.3390\/cancers13205041"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"18408","DOI":"10.1002\/jcp.28476","article-title":"Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma","volume":"234","author":"Huang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.ejso.2015.07.022","article-title":"Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer","volume":"41","author":"Geng","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00432-017-2360-3","article-title":"The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy","volume":"143","author":"Miao","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.21037\/apm-20-2033","article-title":"Prognostic value of pretreatment prognostic nutritional index and lactated dehydrogenase in locally advanced nasopharyngeal carcinoma patients","volume":"10","author":"Xiong","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"104991","DOI":"10.1016\/j.oraloncology.2020.104991","article-title":"Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients","volume":"110","author":"Tu","year":"2020","journal-title":"Oral Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10147-020-01791-x","article-title":"The prognostic role of prognostic nutritional index in nasopharyngeal carcinoma: A systematic review and meta-analysis","volume":"26","author":"Tang","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1080\/01635581.2020.1810715","article-title":"Prognostic Significance of Pretreatment Prognostic Nutritional Index (PNI) in Patients with Nasopharyngeal Carcinoma: A Meta Analysis","volume":"73","author":"Gao","year":"2021","journal-title":"Nutr. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"17795","DOI":"10.1007\/s00432-023-05485-5","article-title":"Prognostic nutritional index and serum lactate dehydrogenase predict the prognosis of nasopharyngeal carcinoma patients who received intensity-modulated radiation therapy","volume":"149","author":"Zhang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/15330338251356541","article-title":"Predictive Effect of Prognostic Nutritional Index on Lymph Node Regression Rate in Patients with Locally Advanced Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy","volume":"24","author":"Song","year":"2025","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1080\/01635581.2020.1798479","article-title":"Significance of Pretreatment C-Reactive Protein, Albumin, and C-Reactive Protein to Albumin Ratio in Predicting Poor Prognosis in Epithelial Ovarian Cancer Patients","volume":"73","author":"Komura","year":"2021","journal-title":"Nutr. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Luan, C.-W., Yang, H.-Y., Tsai, Y.-T., Hsieh, M.-C., Chou, H.-H., and Chen, K.-S. (2021). Prognostic Value of C-Reactive Protein-to-Albumin Ratio in Head and Neck Cancer: A Meta-Analysis. Diagnostics, 11.","DOI":"10.3390\/diagnostics11030403"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.7150\/jca.15401","article-title":"Exploration and Validation of C-Reactive Protein\/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma","volume":"7","author":"Zhang","year":"2016","journal-title":"J. Cancer."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"BSR20180686","DOI":"10.1042\/BSR20180686","article-title":"The prognostic value of C-reactive protein\/albumin ratio in nasopharyngeal carcinoma: A meta-analysis","volume":"38","author":"Gao","year":"2018","journal-title":"Biosci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","article-title":"Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma","volume":"94","author":"Chan","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cncr.11496","article-title":"Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type","volume":"98","author":"Leung","year":"2003","journal-title":"Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1200\/JCO.2006.07.7982","article-title":"Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma","volume":"24","author":"Leung","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2014.10.005","article-title":"High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: A large-scale retrospective and prospective cohort study","volume":"91","author":"Tang","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","article-title":"Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Bossi","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.annonc.2022.11.011","article-title":"ESMO-EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: Adjuvant therapy and first-line treatment of recurrent\/metastatic disease","volume":"34","author":"Bossi","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamaoncol.2025.1597","article-title":"Induction vs Adjuvant Chemoradiotherapy in Patients with High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical Trial","volume":"11","author":"Guo","year":"2025","journal-title":"JAMA Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"104513","DOI":"10.1016\/j.esmoop.2025.104513","article-title":"Advances in individualization of systemic treatment for locoregionally advanced nasopharyngeal carcinoma: A systematic review","volume":"10","author":"Blanchard","year":"2025","journal-title":"ESMO Open"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/377\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:07:45Z","timestamp":1771247265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["medicina62020377"],"URL":"https:\/\/doi.org\/10.3390\/medicina62020377","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]}}}